Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
F.D.A. Approves New Obesity Drug That Will Compete With …
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.
FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new …
Nov 8, 2023 · Eli Lilly says tirzepatide, a drug used to treat type 2 diabetes, also leads to substantial weight loss in diabetes patients. The drug, called Mounjaro for diabetes, will be called Zepbound for...
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
Nov 8, 2023 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs. The drug, which...
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight ...
Nov 8, 2023 · Zepbound is the first and only approved treatment activating two incretin hormone receptors, GIP and GLP-1, to tackle an underlying cause of excess weight.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Sunday, Lilly released new data about retatrutide, an injectable drug that combines GLP-1 and glucagon, plus another hormone called GIP. GIP is thought to improve how the body breaks down...
Questions and answers about the new anti-obesity medications
Jan 1, 2024 · A blockbuster batch of anti-obesity drugs continues to grab headlines and dominate social media posts, and not just because the new year revs up our resolve to shed pounds. The medications — semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) — are backed by science and stunning accounts of people losing as much as 20% ...
Powerful new obesity drug poised to upend weight loss care
Apr 27, 2023 · Drugmaker Eli Lilly reported Thursday that tirzepatide helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial. For those without the disease, the drug has …